Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure
Publisher |
CNBC
Media Type |
audio
Categories Via RSS |
Business
Investing
News
Publication Date |
Oct 20, 2020
Episode Duration |
00:43:54

Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coronavirus vaccine to market. And a moment of zen for Kohl’s as the department store takes on a new project.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review